Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-003372
Filing Date
2025-03-20
Accepted
2025-03-20 16:01:45
Documents
116
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vstm-20241231x10k.htm   iXBRL 10-K 3199160
2 EX-4.2 vstm-20241231xex4d2.htm EX-4.2 173702
3 EX-10.13 vstm-20241231xex10d13.htm EX-10.13 129762
4 EX-10.18 vstm-20241231xex10d18.htm EX-10.18 22595
5 EX-10.19 vstm-20241231xex10d19.htm EX-10.19 95006
6 EX-10.20 vstm-20241231xex10d20.htm EX-10.20 28630
7 EX-10.44 vstm-20241231xex10d44.htm EX-10.44 808832
8 EX-10.45 vstm-20241231xex10d45.htm EX-10.45 38181
9 EX-19.1 vstm-20241231xex19d1.htm EX-19.1 65342
10 EX-21.1 vstm-20241231xex21d1.htm EX-21.1 1549
11 EX-23.1 vstm-20241231xex23d1.htm EX-23.1 17528
12 EX-31.1 vstm-20241231xex31d1.htm EX-31.1 10396
13 EX-31.2 vstm-20241231xex31d2.htm EX-31.2 10423
14 EX-32.1 vstm-20241231xex32d1.htm EX-32.1 5783
15 EX-32.2 vstm-20241231xex32d2.htm EX-32.2 5763
16 EX-99.1 vstm-20241231xex99d1.htm EX-99.1 315364
17 GRAPHIC vstm-20241231x10k003.jpg GRAPHIC 103984
18 GRAPHIC vstm-20241231x10k004.jpg GRAPHIC 35296
19 GRAPHIC vstm-20241231xex19d1001.jpg GRAPHIC 5729
  Complete submission text file 0001558370-25-003372.txt   16225728

Data Files

Seq Description Document Type Size
20 EX-101.SCH vstm-20241231.xsd EX-101.SCH 97531
21 EX-101.CAL vstm-20241231_cal.xml EX-101.CAL 86572
22 EX-101.DEF vstm-20241231_def.xml EX-101.DEF 509273
23 EX-101.LAB vstm-20241231_lab.xml EX-101.LAB 815152
24 EX-101.PRE vstm-20241231_pre.xml EX-101.PRE 709207
119 EXTRACTED XBRL INSTANCE DOCUMENT vstm-20241231x10k_htm.xml XML 2440360
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35403 | Film No.: 25756372
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)